Light chain deposition disease (LCDD) is a rare disorder characterized by glomerular and peritubular amorphous deposits of a monoclonal immunoglobulin (Ig) light chain (LC), leading to nodular glomerulosclerosis and nephrotic syndrome. We developed a transgenic model using site-directed insertion of the variable domain of a pathogenic human LC gene into the mouse Ig kappa locus, ensuring its production by all plasma cells. High free LC levels were achieved after backcrossing with mice presenting increased plasma cell differentiation 
Results
An efficient transgenic strategy to produce high amounts of human pathogenic LCs in mouse. To obtain a high production of the pathogenic human kappa LC, we chose to use a Ig kappa knock-in strategy that proved successful in previous models of Fanconi syndrome and HCDD (17, 19) . We introduced the VJ exon sequence obtained from a patient (F) with biopsy-proven LCDD in place of the J segments, precluding all further mouse kappa rearrangements in homozygous mice ( Figure 1A ). This approach allows an efficient and physiological production of the LC by all B and plasma cells, mimicking the monoclonal status of the patient. Transgenic LCs are chimeric proteins composed of the human variable domain associated to the endogenous mouse constant region and were shown to associate normally to mouse heavy chains (19, 20) . Consequently, in the aim to increase the production of FLC, we further crossed these mice with the DH-LMP2A mice ("DH mice" hereafter) in which the HC locus was invalidated by the targeted insertion of the Epstein Barr virus protein LMP2A that mimics BCR signalling and allows complete B cell development ( Figure   1B ) (21) . DH mice feature increased plasma cell differentiation despite the absence of endogenous HCs (22) . Consequently, LCDD mice, corresponding to the double homozygous DH and F strain (F-DH), closely recapitulate the features of monoclonal gammopathy with an elevated number of plasma cells producing the human/mouse chimeric FLC ( Figure 1 , C and D). Using this strategy, we obtained serum FLC levels similar to those observed in patients with LCDD (23) . Serum production of FLC progressively increased with age and lasted during the life-span of the animals. Bence-Jones proteinuria was readily detectable in 5 month-old mice (( Figure 1E ).
Severe kidney failure induces premature death of LCDD mice. Two cohorts of F-DH mice (total of 12 mice composed of 7 males and 5 females) were monitored daily from the fifth month for external signs of morbidity (see methods). No signs of morbidity were observed in mice before 6 months of age. The first mouse was sacrificed at 6 months due to visible alteration of general condition. Then the entire cohorts had to be sacrificed within the first 14 months, with a median survival of 8.5 months (Figure 2A ). DH mice were used as control, since, similarly to F-DH mice, they do not produce complete antibodies (10 mice, 5 males and 5 females). At 14 months, in our pathogen-free facility, all DH mice were healthy ( Figure 2A ). Having demonstrated that the early death of F-DH mice was not due to immunodeficiency, we analysed their renal function. We first explored the progression of albuminuria with age ( Figure 2B ). No albuminuria was observed in 2 or 6 month-old F-DH mice as compared to control mice. At 8 months of age, mice without signs of morbidity presented a significant increase in albuminuria compared to controls ( Figure 2B ). Mice Electron microscopy revealed characteristic linear "powdery punctuate" deposits on the inner aspect of glomerular BMs and the outer aspect of tubular BM, diffuse thickening of tubular and glomerular BMs, and expanded mesangial areas with massive accumulation of electrondense material ( Figure 3C ). Finally, immunoelectron microscopy using gold-labelled antimouse kappa LC showed intense staining confirming the composition of the deposits ( Figure   3D ). Lesions of thrombotic microangiopathy with widening of the subendothelial zone by electron lucent material were seen in some glomeruli from 6 month-old mice and in most glomeruli from mice sacrificed at humane endpoints ( Figure 5A ). Among these genes, 192 were deregulated compared to both controls, with 155 upregulated and 37 downregulated genes (Supplemental Figure 5A and B).
We performed a C2 canonical pathway analysis from the Molecular Signatures Database (MSignDB v6.2) (25, 26) which revealed that the cell cycle (mitotic) was the main modified pathway ( Figure 4B ). Among the 20 more activated pathways (FDR q value from 5.93*10 -22 to 1.78*10 -5 ), 9 were directly related to the cell cycle ( Figure 4B and Supplemental Table 1 ).
Interestingly, all deregulated genes involved in the cell cycle were upregulated ( Figure 4A , Supplemental Figure 5A and B and Supplemental Table 1 ). Deregulated genes in pathways not directly related to the cell cycle, like AURORA B, PLK1, FOXM1 or E2F, in fact frequently overlap with those of the cell cycle (Supplemental Table 1 ). Finally, beside the cell cycle, and as expected, we found 24 deregulated genes involved in the matrisome pathway (18 upregulated, 6 downregulated), including the previously described upregulation of Tenascin C (Tnc) and CTGF, known to be involved in glomerulosclerosis and interstitial fibrosis ( Figure 4 , A and B, supplemental Figure 5B and supplemental Table 1 ) (16, 27, 14) .
However, we did not find any activation of pathways related to TGFβ despite its established role in glomerulosclerosis. Immunostaining for Ki67 ( Figure 4D ) and Tenascin C (Supplemental Figure 6 ) in 6-month-old mice confirmed extensive cell cycle and ECM remodelling, respectively, in the glomeruli of F-DH mice.
LCDD LC induces ER stress and sensitizes plasma cell to proteasome inhibitors. Several studies tend to demonstrate that the production of a pathogenic monoclonal Ig or Ig fragment could influence plasma cell fitness and sensitivity to treatments through a general cellular stress involving ER stress, decreased autophagy and oxidative stress (17, 28) . and 213 genes, respectively upregulated and downregulated in κF-DH vs both controls (Supplemental Figure 7A and B). We performed a C2 canonical pathway analysis from the Molecular Signatures Database (MSignDB v6.2) and found that among the upregulated genes, the only significant pathways were related to the unfolded protein response (UPR) ( Figure 5B and Supplemental Table 2 ). Genes of the UPR pathway upregulated in F-DH PCs as compared to both controls are indicated on the MA-plots ( Figure 5A ) showing that they were not only upregulated but, as expected, were also highly expressed in PCs (29) . Analyses using a classification of the differentially expressed genes by biological process ("GO biological process" from the Molecular Signatures Database) showed that the three most significant pathways were related to topologically incorrect proteins and ER stress, further suggesting that the activation of the UPR was likely due to the pathogenic LCDD LC ( Figure 5C and Supplemental Table 3 ). Among the twenty most significant overlaps, nine were related to response to incorrect protein folding, ER stress or general response to stress. Downregulated genes were associated with ECM modification, hematopoietic lineage and G protein-coupled protein signalling (Supplemental Table 4 ). Gene set enrichment analyses (GSEA) on total genes confirmed that the UPR was significantly enriched in F-DH PCs compared to both WT and DH cells (Supplemental Figure 7C ). We performed real-time PCR on selected genes (Herpud1, Hspa5, Ddit3, Xbp1s) and confirmed a similar tendency for upregulation of genes involved in UPR even if, consistent with RNA-Seq analysis, no increase in Xbp1s was observed ( Figure 5D ). Having demonstrated that LCDD LC-producing PCs have an exacerbated UPR, we next verified if such ER stress could sensitize PCs to proteasome inhibitors (PI), as we previously showed in a HCDD mouse model (17) . We treated mice with suboptimal doses of bortezomib (Bz) for two consecutive days to evaluate the level of PC depletion. This protocol led to a partial (about 2 fold) reduction of the absolute number of PCs in WT and DH mice (45.16 % and 57.54 % of depletion, respectively) as previously demonstrated (17) . In contrast, PC depletion in F-DH mice was far more efficient than in control mice with a mean depletion of 84.46 % corresponding to 6.44 fold reduction in absolute PC number ( Figure 5E ).
Removal of circulating LC leads to a rapid decrease of renal LC deposits and protects mice from kidney failure.
The efficient response to PI prompted us to evaluate the effect of LC removal on renal lesions evolution. Weekly injections of Bz + cyclophosphamide led to an almost complete (> 10-fold reduction) and sustained depletion of circulating  LC (Supplemental Figure 8) . Treatment was administered for 2 months and all mice were subsequently sacrificed and processed for renal histological studies, except for mice reaching humane endpoints during the course of the experiment, which were immediately sacrificed. As shown in Figure 6A , treatment completely protected mice from early death. Kidneys from treated and non-treated mice were analysed for LC deposits and scores were established to compare the amount of lesions. As expected, treated mice presented significantly less abundant renal LC deposits as compared to non-treated mice ( Figure 6 B and C). Interestingly, kidney lesions after treatment were also significantly lower as compared to non-treated 6-month-old mice (used in Figure 2 While serum creatinine was significantly increased in non-treated mice, it was maintained at normal levels in treated mice, which, compared to control 6-month-old mice, showed slight but non-significant increase in albuminuria ( Figure 6E ).
Discussion
We herein described the first transgenic mouse model fully reproducing specific renal lesions and kidney dysfunction observed in human LCDD. We previously characterized another model of MIDD using a similar transgenic strategy, i.e. targeted insertion of a human pathogenic Ig gene into the mouse kappa locus (17) . In this model, the human Ig gene was obtained from a patient with biopsy-proven HCDD and was composed of a truncated γ1 HC lacking the CH1 domain. Production of the pathogenic Ig in this model induced kidney lesions closely resembling those observed in human MIDD, including diffuse tubular and glomerular BM thickening and mesangial deposits. However, mice did not develop glomerulosclerosis, a hallmark of HCDD (5), nor exhibited glomerular dysfunction (normal creatinine and albuminuria). We suspected the genetic background to be involved, since C57BL6 and 129SV mice were previously shown to be highly resistant in models of nephron reduction or diabetic nephropathy (30) (31) (32) . However, we could not exclude that the low level of circulating HC (~30-40 µg/ml) precluded pathological and clinical progression of the disease. In the present LCDD mouse model, we used a new strategy to obtain high levels of circulating human FLC (33, 18) . We inserted the pathogenic V domain of a human LC into the kappa locus and crossed the mice with DH-LMP2A mice that display increased plasma cell development in the absence of Ig heavy chains (21, 22, 18) . Using this approach, production of a chimeric FLC (composed of a human pathogenic V4 domain and the mouse C domain) occurred in virtually all plasma cells and kappa LC serum levels reached more than 1g/l in F-DH mice, which is similar to that observed in LCDD patients (23) . Similar In vivo treatment, surgery and biochemical parameters Mice were treated with Bortezomib 0,75mg/kg (56) (Velcade®, Janssen Cilag) and cyclophosphamide (Endoxan®, Baxter) (2mg/kg) once a week during 2 months. Bortezomib was injected subcutaneously and cyclophosphamide was injected intraperitoneally. To test the sensitivity of plasma cells to Bortezomib, we daily injected a sub-optimal dose of Bortezomib for two days as previously described (17) . All injections were performed under anesthesia.
Biochemical parameters were measured on overnight urine collection and blood samples were obtained by retro-orbital puncture under anesthesia. Serum concentrations of creatinine were measured on a Konelab 30 analyser with a creatinine enzymatic test (ThermoFisher Scientific). Urine albumin concentrations were measured using an albumin mouse ELISA kit (Abcam), according to the manufacturer's recommendations.
Glomeruli extraction
Isolation of kidney glomeruli from mice was derived from Takemoto and al. (57) . Briefly, mice were perfused in the heart with magnetic 4.5µm diameter Dynabeads. Kidneys were minced, digested by Dnase I (Roche) and collagenase IV (Sigma-Aldrich), filtered, and glomeruli were isolated using a magnetic rack. Total RNA from purified glomeruli were obtained using miRNeasy Mini kit (Quiagen).
Flow cytometry
Intracellular staining was performed using the Intraprep™ kit (Beckman Coulter). Flow cytometry analysis were performed on a BD Pharmingen LSRFortessa® cytometer. Data were analyzed with BD FACSDiva software (BD Biosciences). Antibodies used are listed in the Supplemental Table 5 Western Blot Serum proteins were separated by reducing SDS-PAGE (10%) and transferred onto polyvinylidene difluoride membranes (Millipore). Membranes were blocked in 5% milk Trisbuffered saline (TBS), then incubated with appropriate antibodies in 3% milk TBS (supplemental Table 2 ), washed three times with TBS 0.1 % tween and revealed by chemiluminescence (ECL, Pierce).
Pathologic studies
Kidney samples were processed for light microscopic examination, immunofluorescence and electron microscopic studies, as previously described (19, 58) . Briefly, immunofluorescence was performed on organs included in OCT and snap frozen in isopentane using a Snap Frost 2 (Excilone). Cryosections of 8µm were fixed with cold acetone, blocked with PBS 3% BSA and stained with appropriate antibodies (Supplemental Table 5 ). For ki-67 intracellular staining, fixed slides were permeabilized with PBS-tween 0.1 % and then stained in PBStween overnight. Total positive glomerular cells were counted manually on a complete kidney section. Slides were observed on a NiE microscope (Nikon). Immunoelectron microscopy was made on samples fixed with 4% glutaraldehyde in PBS and embedded in resin (TAAB Labs).
Ultra-thin sections were processed for EM studies, incubated with anti- gold-conjugated and examined with a JEOL JEM-1010 electron microscope as previously described (59) . Periodic acid schiff (PAS) stainings were prepared on paraffin-embedded kidney sections and examined by light microscopy on a NiE microscope (Nikon). Lesions scores were quantified on renal sections in blind experiments carried out by at least three independent experimenters.
Lesions scores ranged from 0 to 4 (0 =absent; 1 = weak deposits on glomerular and tubular basement membranes ; 2 = Bright deposits GBM and TBM but normal structures (absence of sclerosis) ; 3 = Bright deposits on GBM and TBM, start of sclerosis and abnormal structures in some tubules and glomeruli ; 4 = Heavy deposits on GBM and TBM and glomerular sclerosis). Representative images with scores are depicted in Figure 3 .
In vitro stimulations
Spleen B cells were isolated and stimulated in vitro (1x10 6 cell/mL) with 1µg/mL of LPS (InVivoGen) for four days, in DMEM supplemented with 10% FCS. 1.10 6 cells were used for flow cytometry analysis.
ELISA
Serum were analyzed for the presence of kappa light chains, as previously described (58) .
Plates were read at 405nm with a Multiskan FC® spectrophotometer (Thermo scientific).
Transcriptional analysis
Total RNA was extracted using TRI Reagent (Ambion). After digestion of the remaining Venn diagrams were created using Venny 2. Urine albumin and (C) serum creatinine levels in 2 to 8-month-old kF-DH, DH and WT mice, and in kF-DH mice at humane endpoint (ɵ). Urine albumin in kF-DH mice started to increase at 8 months while a strong increase of serum creatinine appeared only in unhealthy mice. Survival data were analyzed using log-rank (Mantel-Cox) test and comparisons between 2 groups were calculated using the non-parametric Mann-Whitney test. Means are ± SEM and only significant p values are indicated. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Immunoelectron microscopy (original magnification x40,000). Presence of anti-kappa gold-conjugated particles along the inner aspect of glomerular basement membrane (arrow-head). All data are representative of at least 3 kidneys in each group.
